Research Topics
| David R J OwenSummaryAffiliation: Imperial College Country: UK Publications
| Collaborators
|
Detail Information
Publications
Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety?David R Owen
Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK
J Psychopharmacol 27:119-22. 2013..In this paper we discuss this issue in relation to psychiatry using a new and interesting example of how genotyping might help rescue an apparently failed novel treatment in anxiety disorders...
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28David R Owen
Division of Experimental Medicine, Department of Medicine, Imperial College London, Hammersmith Hospital, London, UK
J Cereb Blood Flow Metab 32:1-5. 2012....
Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced USDavid R Owen
Department of Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, England
Radiology 255:638-44. 2010..To determine if the number of nontargeted microbubbles retained in human carotid plaque is sufficient to be detected with ultrasonography (US)...
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammationDavid R Owen
Department of Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, London, UK
J Cereb Blood Flow Metab 30:1608-18. 2010..The functional significance of differences in binding characteristics warrants further investigation...
Mixed-affinity binding in humans with 18-kDa translocator protein ligandsDavid R J Owen
Division of Experimental Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
J Nucl Med 52:24-32. 2011....
Imaging of atherosclerosisD R J Owen
Department of Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom
Annu Rev Med 62:25-40. 2011..Each technique has its own strengths and drawbacks. In this article, we review the various imaging modalities used for the evaluation and quantification of atherosclerosis...
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomographyOliver Gaemperli
Medical Research Council Clinical Sciences Centre and National Heart and Lung Institute, Hammersmith Hospital, Imperial College, London, UK
Eur Heart J 33:1902-10. 2012....
Late-phase contrast-enhanced ultrasound reflects biological features of instability in human carotid atherosclerosisJoseph Shalhoub
Academic Section of Vascular Surgery, Department of Experimental Medicine, Imperial College London, and Charing Cross Hospital, London W6 8RF, UK
Stroke 42:3634-6. 2011..We hypothesized that microbubbles are retained in areas of plaque inflammation, aiming to examine whether LP-CEUS signal reflects plaque biology...
Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligandsDavid R J Owen
Division of Experimental Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
Int Rev Neurobiol 101:19-39. 2011..This review describes the principles of PET imaging, the rationale and challenges in targeting the TSPO as means of quantifying microglial activation in vivo, and disease applications that have been studied with TSPO-PET hitherto...
Identification and assessment of plasma lysozyme as a putative biomarker of atherosclerosisVahitha B Abdul-Salam
Experimental Medicine, Imperial College London, Du Cane Road, London W12 0NN, England
Arterioscler Thromb Vasc Biol 30:1027-33. 2010..To identify a plasma biomarker of atheromatous disease...
Motion-sensitized driven equilibrium for blood-suppressed T2* mappingRexford D Newbould
GSK Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
J Magn Reson Imaging 34:702-9. 2011..To combine a motion-sensitized driven equilibrium (MSDE) preparation with a multi-echo spoiled gradient-echo sequence (SPGR) to suppress the blood signal intensity in T2* mapping of carotid plaques and liver...
Towards molecular imaging of multiple sclerosisDavid R J Owen
Division of Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK
Mult Scler 17:262-72. 2011..In the future, molecular imaging could assist clinical decision-making with patient stratification for optimization of treatment selection...
